Originally published on www.technocracy.news Dr. Russell Blaylock warns that not only do face masks fail to protect the healthy from getting sick, but they also create serious health risks to the wearer. The bottom line is that if you are not sick, you should not wear a face mask. read more
Category Archives: Uncategorized
Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors.
PMID: Pharmacol Res. 2020 Mar 6 ;156:104749. Epub 2020 Mar 6. PMID: 32151683 Abstract Title: Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors. Abstract: Preclinical and clinical data indicate that cannabidiol (CBD), a non-psychotomimetic compound from the Cannabis sativa plant, can induce antipsychotic-like effects. In …
CBD reverts the mesenchymal invasive phenotype of breast cancer cells induced by the inflammatory cytokine IL-1β.
PMID: Int J Mol Sci. 2020 Mar 31 ;21(7). Epub 2020 Mar 31. PMID: 32244518 Abstract Title: CBD Reverts the Mesenchymal Invasive Phenotype of Breast Cancer Cells Induced by the Inflammatory Cytokine IL-1β. Abstract: Cannabidiol (CBD) has been used to treat a variety of cancers and inflammatory conditions with controversial results. In previous work, we …
Cannabidiol: A brief review of its therapeutic and pharmacologic efficacy in the management of joint disease.
PMID: Cureus. 2020 Mar 23 ;12(3):e7375. Epub 2020 Mar 23. PMID: 32328386 Abstract Title: Cannabidiol: A Brief Review of Its Therapeutic and Pharmacologic Efficacy in the Management of Joint Disease. Abstract: Cannabis use in the management of musculoskeletal diseases has gained advocacy since several states have legalized its recreational use. Cannabidiol (CBD), a commercially available, non-neurotropic …
Cannabidiol and other non-psychoactive cannabinoids for prevention and treatment of gastrointestinal disorders.
PMID: Int J Mol Sci. 2020 Apr 26 ;21(9). Epub 2020 Apr 26. PMID: 32357565 Abstract Title: Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals? Abstract: is an aromatic annual flowering plant with several botanical varieties, used for different purposes, like the production of fibers, the production of oil …
Two-weeks treatment with cannabidiol improves biophysical and behavioral deficits associated with experimental type-1 diabetes.
PMID: Neurosci Lett. 2020 May 1 ;729:135020. Epub 2020 May 1. PMID: 32360935 Abstract Title: Two-weeks treatment with cannabidiol improves biophysical and behavioral deficits associated with experimental type-1 diabetes. Abstract: The prevalence rates of depression and anxiety are at least two times higher in diabetic patients, increasing morbidity and mortality. Cannabidiol (CBD) has been identified …
CBD inhibitory effects on the NLRP3 inflammasome may contribute to the overall anti-inflammatory effects reported for this phytocannabinoid.
PMID: J Nat Prod. 2020 May 6. Epub 2020 May 6. PMID: 32374168 Abstract Title: Inhibitory Effect of Cannabidiol on the Activation of NLRP3 Inflammasome Is Associated with Its Modulation of the P2X7 Receptor in Human Monocytes. Abstract: Cannabidiol (CBD), a phytocannabinoid, has been reported to have anti-inflammatory effects associated with NLRP3 inflammasome activation, but …
CBD seems to exert an anti-inflammatory and antioxidant activity favoring a faster resolution of oral mucositis.
PMID: Oral Dis. 2020 May 13. Epub 2020 May 13. PMID: 32400905 Abstract Title: Cannabidiol on 5-FU-induced oral mucositis in mice. Abstract: PURPOSE: The aim of this study was to evaluate the clinical, histological, hematological and oxidative stress effects of cannabidiol (CBD) in mice with induced oral mucositis.METHODS: We used 90 mice of the CF-1 …
From Cannabis sativa to cannabidiol: promising therapeutic candidate for the treatment of neurodegenerative diseases.
PMID: Front Pharmacol. 2020 ;11:124. Epub 2020 Mar 6. PMID: 32210795 Abstract Title: Fromto Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases. Abstract: , commonly known as marijuana, contains a pool of secondary plant metabolites with therapeutic effects. BesidesΔ9-tetrahydrocannabinol that is the principal psychoactive constituent of, cannabidiol (CBD) is the most abundant nonpsychoactive …
The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis.
PMID: Inflamm Res. 2020 Jun ;69(6):549-558. Epub 2020 Apr 1. PMID: 32239248 Abstract Title: The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis. Abstract: PURPOSE: Cannabis has been used for thousands of years in many cultures for the treatment of several ailments including pain. …
Health Time 